Comparison of 2D conventional, 3D conformal, and intensity-modulated treatment planning techniques for patients with prostate cancer with regard to target-dose homogeneity and dose to critical, uninvolved structures-Reference-Cited by-同舟云学术

Comparison of 2D conventional, 3D conformal, and intensity-modulated treatment planning techniques for patients with prostate cancer with regard to target-dose homogeneity and dose to critical, uninvolved structures

Published:1999-11 Issue:4 Volume:24 Page:255-263
ISSN:0958-3947
Container-title:Medical Dosimetry
language:en
Short-container-title:Medical Dosimetry

Author:

Oh Christine E,Antes Kyle,Darby Michael,Song Sherry,Starkschall George

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Radiological and Ultrasound Technology

Reference4 articles.

1. Kassabian, V.S.; Graham, S.D. Urologic and male genital cancers. In: Murphy, G.; Lawrence, W.; Lenhard, R.; editors. Clinical Oncology. 2nd ed. Washington, DC. The American Cancer Society, Inc.; 1995; 311–329.

2. The prostate;Hanks,1994

3. Radiotherapy simulators;Sherouse,1996

4. Dose-volume distributions;Niemierko;Med. Phys.,1994

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Développement des modèles de culture cellulaire de muscle en 3D : de nouvelles opportunités pour les productions animales;INRAE Productions Animales;2023-09-13

2. Dosimetric analysis of patients receiving radiotherapy with VMAT technique in localized prostate cancer and its correlation with side effects;Journal of Cancer Research and Therapeutics;2022

3. 3D in vitro models of skeletal muscle: myopshere, myobundle and bioprinted muscle construct;Veterinary Research;2021-05-19

4. Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique;The British Journal of Radiology;2015-02

5. Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer;Strahlentherapie und Onkologie;2015-01-15